biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by zwerp2000on May 28, 2016 7:37am

142 Views

Post# 24912635

RE:JENSEN BIOTHERAPEUTICS!!!

You'd have to think something good is going on with BIOAF if giants like Alexion and Jensen are asking them to present. Why else would they bother to ask this tiny company to be involved with the forum? They are clearly following them and know what they are doing? Hopefully it's just a matter of time before a deal is made.

Bullboard Posts

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal